![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Duclos P. Hofmann C-A.
Publisher: Adis International
ISSN: 0114-5916
Source: Drug Safety, Vol.24, Iss.15, 2001-01, pp. : 1105-1112
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Combination vaccines essential for immunisation schedules
Inpharma, Vol. 1, Iss. 1229, 2000-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Technologies to Improve Immunisation Safety
By Clements C.J. Aguado M.T. Jódar L.
Drug Safety, Vol. 24, Iss. 14, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
World Health Organization Classification of Myelodysplastic Syndromes
Current Pharmaceutical Design, Vol. 18, Iss. 22, 2012-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
One in four biologicals subject to safety actions postapproval
Reactions Weekly, Vol. 1, Iss. 1226, 2008-01 ,pp. :